Visits: 1536, Avg visit time (secs): 217,14 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 601 | 39,13% | |
| /recipients.html | 126 | 8,20% |
| /msd/efsd-msd-recipients-islet.html | 106 | 6,90% |
| /new_horizons/recipientsnh.html | 49 | 3,19% |
| /lilly/efsd-lilly-recipients.html | 43 | 2,80% |
| /novo-t2/efsd-novo-t2-recipients.html | 34 | 2,21% |
| /amylin/efsd-amylin-recipients.html | 34 | 2,21% |
| /novo-clinical-t2/efsd-novo-clin-t2-recipients.html | 30 | 1,95% |
| /dcure/efsd-dcure-recipients.html | 27 | 1,76% |
| /gsk/efsd-gsk-recipients.html | 27 | 1,76% |
| /efsd-grant/efsd-clinres-recipients.html | 26 | 1,69% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 719 | 46,81% |
| /sanofi-aventis/micro_macro/recipientsmicro_macro.html | 107 | 6,97% |
| /servier/efsd-servier-recipients.html | 57 | 3,71% |
| /msd/efsd-msd-recipients-islet.html | 43 | 2,80% |
| /programmes.html | 35 | 2,28% |
| /pfizer/efsd-pfizer-recipients.html | 26 | 1,69% |
| /novo-clinical-t2/efsd-novo-clin-t2-recipients.html | 26 | 1,69% |
| /new_horizons/recipientsnh.html | 25 | 1,63% |
| /efsd-jdrf-novo/efsd-jdrf-novo-t1-recipients.html | 25 | 1,63% |
| /amylin/efsd-amylin-recipients.html | 24 | 1,56% |
| /medtronic/efsd-medtronic-recipients.html | 24 | 1,56% |